The ongoing COVID-19 pandemic has posed a significant global challenge to healthcare systems. Every country has seen multiple waves of this disease, placing a considerable strain on healthcare resources. Across the world, the pandemic has motivated diligent data collection, with an enormous amount of data being available in the public domain. In this manuscript, we collate COVID-19 case data from around the world (available on the World Health Organization (WHO) website), and provide various definitions for waves. Using these definitions to define labels, we create a labelled dataset, which can be used while building supervised learning classifiers. We also use a simple eXtreme Gradient Boosting (XGBoost) model to provide a minimum standard for future classifiers trained on this dataset and demonstrate the utility of our dataset for the prediction of (future) waves. This dataset will be a valuable resource for epidemiologists and others interested in the early prediction of future waves. The datasets are available from https://github.com/RamanLab/COWAVE/.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368260PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0284076PLOS

Publication Analysis

Top Keywords

dataset building
8
prediction future
8
future waves
8
dataset
5
cowave labelled
4
labelled covid-19
4
covid-19 wave
4
wave dataset
4
building predictive
4
predictive models
4

Similar Publications

Predicting Discharge Destination from Inpatient Rehabilitation Using Machine Learning.

Am J Phys Med Rehabil

December 2024

Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI, 53226.

Predicting discharge destination for patients at inpatient rehabilitation facilities is important as it facilitates transitions of care and can improve healthcare resource utilization. This study aims to build on previous studies investigating discharges from inpatient rehabilitation by employing machine learning models to predict discharge disposition to home versus non-home and explore related factors. Fifteen machine learning models were tested.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

MIRAL R&D&I Multimedia, San Diego, CA, USA.

Background: A decline in Instrumental Activities of Daily Living (IADLs) indicates cognitive impairment, a marker of early detection of Alzheimer's disease (AD). Obtaining hand information within the assessment of IADLs may be an innovative approach to predicting cognitive decline. Hands play a vital role while performing IADL and can be used in assessing human visuomotor skills.

View Article and Find Full Text PDF

Background: The extracellular deposition of amyloid-beta (Aβ) and intracellular aggregation of hyperphosphorylated tau proteins stand as histopathological hallmarks of Alzheimer's disease (AD). The spatial-temporal relationship between the Aβ pathway and tau pathophysiology in AD, plays a crucial role in comprehending the pathogenesis and progression of AD. Understanding the interrelationship between Aβ and tau, is crucial to elucidate the failure of previous therapeutic strategies and understanding AD progression and will inform the next generation of clinical trials.

View Article and Find Full Text PDF

Background: Standardizing tau pathology quantification in vivo is challenged by differences in binding characteristics between tau-PET tracers. The HEAD study aims to generate a leading, longitudinal head-to-head dataset of MK-6240, Flortaucipir, RO948, and PI-2620 tau-PET to harmonize these tracers' outcomes and develop tools allowing for the generalization of findings across large studies and trials. Here, we present current advancements in building the HEAD study cohort and dataset.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

University of Pennsylvania, Philadelphia, PA, USA.

Background: Alzheimer's disease (AD) is a complex neurodegenerative disorder that has impacted millions of people worldwide. Identifying different risk groups converting to AD during the mild cognitive impairment (MCI) stage and determining their genetic basis would be immensely valuable for drug discovery and subsequent clinical treatment. Previous studies typically clustered subgroups by unsupervised learning techniques, neglecting the survival information.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!